Houlihan Lokey Advises Tyber Medical
Houlihan Lokey is pleased to announce that Tyber Medical, LLC, has agreed to be acquired by Montagu Private Equity (Montagu). As part of the transaction, Tyber Medical will combine with Resolve Surgical Technologies (Resolve) and Intech to form a next-generation solutions provider to the medical device industry. The transaction is subject to the satisfaction of customary closing conditions, including the receipt of required regulatory approvals.
Tyber Medical, headquartered in Bethlehem, Pennsylvania, is a privately held designer, developer, and manufacturer of off-the-shelf private-label orthopedic implantable devices and instrumentation. It offers fully integrated solutions, delivering certified medical devices under blue-chip client brands with design, regulatory, and advanced manufacturing expertise. Since its founding in 2012, the company has released more than 50 spine, extremity, and trauma systems.
Montagu, founded in 1968, is a leading middle-market private equity firm specializing in carve-out and other first-time buyout investments across healthcare, financial services, critical data, digital infrastructure, and education sectors. The firm is headquartered in London, United Kingdom, with offices across the U.S. and Europe. Montagu has €11 billion in assets under management and partners with companies between €200 million and €1 billion in enterprise value.
Subject to customary regulatory approvals and closing conditions, Tyber Medical will be combined with Montagu’s existing portfolio companies: Resolve, a leading orthopedic device private label OEM providing contract device design and manufacturing services, and Intech, a leader in the co-development and manufacturing of complex orthopedic surgical devices. The combined three-part entity will be the first to offer a truly integrated, global solution that provides proprietary market-cleared technologies and development manufacturing scale to orthopedic device customers.
This transaction further highlights Houlihan Lokey’s leadership in the medical device outsourcing sector. Houlihan Lokey’s Healthcare Group is among the largest and most active dedicated healthcare investment banking groups in the world, closing 20+ transactions in the past 18 months. In 2023, the group closed 34 transactions and was ranked by LSEG (formerly Refinitiv) as the No. 1 advisor for all global healthcare M&A transactions, excluding accounting firms and brokers.
Houlihan Lokey served as the exclusive financial advisor to Tyber Medical.